Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)

NCT04612556 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Asthma; Eosinophilic
Severe Asthma
Late-Onset Asthma

Interventions

DRUG: Mepolizumab 100 MG [Nucala]

Sponsor

Aristotle University Of Thessaloniki

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]